ISSN: 2329-9053

Journal of Molecular Pharmaceutics & Organic Process Research
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Editorial   
  • J Mol Pharm Org Process Res 2013, Vol 1(2): 105
  • DOI: 10.4172/2329-9053.1000105

Aptamer Functionalized Nanoparticles for Cancer Targeting

Carolina De Aguiar Ferreira1 and Andre Luis Branco De Barros2*
1Centro de Desenvolvimento da Tecnologia Nuclear-CDTN, , Av. Antônio Carlos, 6627, 31270-091 Belo Horizonte, MG, Brazil
2Faculty of Pharmacy, Federal University of Minas Gerais, Av. Antônio Carlos, 6627, 31270-091 Belo Horizonte, MG, Brazil
*Corresponding Author : Andre Luis Branco De Barros, Faculty of Pharmacy, Federal University of Minas Gerais, Av. Antônio Carlos, 6627, 31270-091 Belo Horizonte, MG, Brazil, Tel: +55 31 3409 6840, Email: brancodebarros@yahoo.com.br

Received Date: Jul 25, 2013 / Accepted Date: Aug 21, 2013 / Published Date: Sep 02, 2013

Keywords: Aptamer; Anticancer delivery systems; Nanoparticles; Tumor treatment; Tumor diagnosis

Citation: Ferreira CDA, De Barros ALB (2013) Aptamer Functionalized Nanoparticles for Cancer Targeting. J Mol Pharm Org Process Res 1: 105. Doi: 10.4172/2329-9053.1000105

Copyright: ©2013 Ferreira CDA, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited

Top